The majority-owned CuraGen subsidiary also said revenue from grants slipped 29 percent in the period to $500,000 from $700,000 year over year.
Breaking down the numbers for this period, CuraGen said 454 generated nearly $4.5 million in product sales while the 454
In its statement today, CuraGen did not disclose 454's figures from the first quarter 2005; the information was obtained from CuraGen's website.